Search Results for “aging” – Page 92 – media

Standalone Healthcare Sector is Independent from GE

General Electric (GE) has a new spinoff with great potential in the healthcare sector, as a separate standalone firm. This would enable great opportunities for growth and innovation.
- Source: HealthcareIT
- 707
- July 2, 2018
Company Insight healthcare
Amazon Acquires Online Pharmacy

The latest in digital health news is that Amazon would be acquiring a virtual pharmacy named PillPack. Amazon’s website which is famous for online shopping is planning to expand by also including prescription medication.
- Source: MobiHealthNews
- 593
- July 2, 2018
Amazon Company Insight digital health
3 Amazing (and Real) Medical Inventions!

Saving lives through accurate diagnosis followed by swift treatment is the major outcome of new and pioneering medical inventions and technologies. And it is encouraging to see that the healthcare industry is heading towards this goal. With this in mind, we have listed three medical advances which have helped to change the medical scenario throughout the world.
- Source: News 24
- 2,154
- June 29, 2018
digital health Market Views medical device
Brain U Online Delays Dementia

The subscription-based consumer-friendly service named Brain U Online provides cognitive tasks with exercise to delay the progression of dementia by 2.5 years and reduce its negative effect by 45%.
- Source: MobiHealthNews
- 735
- June 28, 2018
Dementia mHealth New Approvals
Celgene Collaboration with Skyhawk for Drug Discovery against Neurological Diseases

To develop small molecules which can target RNA mis-splicing in neurological diseases, Celgene is launching a $60 million collaboration with Skyhawk Therapeutics. Celgene received the option to develop up to five drug molecules for correcting neurological diseases such as Huntington’s disease, amyotrophic lateral sclerosis etc. The $60 million payment includes milestones, license fees and royalties.
- Source: FierceBiotech
- 673
- June 28, 2018
cancer Company Insight neurological
Dementia Discovery Fund, Surpassed Funding Target

The DDF initially aimed to raise £130 million with committed investments from GlaxoSmithKline, Biogen, Eli Lilly, Pfizer and Takeda, Johnson & Johnson, as well as the U.K. government’s Department of Health and the nonprofit Alzheimer’s Research UK.
- Source: FierceBiotech
- 609
- June 27, 2018
Company Insight Dementia funding
New UltraSound System Launched by Siemens Healthneers

German Based Medical Tech Company Siemens Healthineers recently launched “Acuson Sequoia” a new imaging ultrasound system which enables imaging of different sized patients with unchanging clarity. The newly developed devices provide advanced high-powered architecture Deep Abdominal Transducer (DAX) and other improvements to elastography and contrast-enhanced ultrasound. To enable better diagnosis the device can produce penetration of up to 40cm to offer high-resolution imaging.
- Source: Verdict Medical Devices
- 597
- June 27, 2018
Company Insight imaging medtech Siemens
Overuse of Multivitamins could be Harmful

Usage of multivitamins either through prescription or on own accord possibly crossed a limit in the past few years. New research published in Journal of American College of Cardiology reveals that health supplements can increase the risk of heart issues.
- Source: India Times
- 1,322
- June 26, 2018
Researches vitamin
Call for HIMSS19 Global Conference Speaker Proposals

There will be a total of twenty-four education categories/topics, which includes five new topics namely consumerization of health, grand societal challenges, healthy aging and technology, population and public health management as well as supply chain management.
- Source: MobiHealthNews
- 649
- June 26, 2018
Company Insight digital health health IT HIMSS
AstraZeneca’s Durvalumab Receives Go-Ahead from DCGI to Market in India

Last Friday, pharma giant AstraZeneca announced that it had received the go-ahead from the Drug Controller General of India (DCGI) to import and market durvalumab (ImfinziTM) in India. The receipt of this permission paves the way for the launch of durvalumab (ImfinziTM) in India. Durvalumab which is a patented drug of Astra-Zeneca, received permission in India to provide treatment for patients with unresectable non-small cell lung cancer and metastatic urothelial carcinoma.
- Source: United News of India
- 2,553
- June 26, 2018
AstraZeneca cancer India New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.